Gene: CHMP7
Official Full Name: charged multivesicular body protein 7provided by HGNC
Gene Summary: Involved in several processes, including midbody abscission; mitotic nuclear division; and vacuolar transport. Located in chromatin; cytosol; and nucleus. Part of several cellular components, including bounding membrane of organelle; kinetochore microtubule; and midbody. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23372 | CHMP7 Knockout cell line (HeLa) | Human | CHMP7 | 1:3~1:6 | Negative | Online Inquiry |
KO23373 | CHMP7 Knockout cell line (HCT 116) | Human | CHMP7 | 1:2~1:4 | Negative | Online Inquiry |
KO23374 | CHMP7 Knockout cell line (HEK293) | Human | CHMP7 | 1:3~1:6 | Negative | Online Inquiry |
CHMP7 Gene Knockout Cell Lines are meticulously engineered cell lines that have undergone precise genetic modification to disrupt the CHMP7 gene, a crucial component in the mechanism of endosomal sorting and microautophagy. By utilizing CRISPR/Cas9 technology, these cell lines permit a detailed exploration of CHMP7's role in cellular processes and its implications in various diseases, including neurodegeneration and cancer.
The primary function of CHMP7 is linked to the regulation of the endosomal sorting complex required for transport (ESCRT), which is involved in the degradation of cellular components and the regulation of cytokinesis. The knockout of the CHMP7 gene allows researchers to study the resultant effects on endosomal trafficking, membrane dynamics, and cellular responses to stress, which are pivotal to understanding disease mechanisms.
In research settings, CHMP7 Gene Knockout Cell Lines are invaluable tools for dissecting the complexities of cellular homeostasis and disease pathology. Their applications span from basic biology to translational research, allowing the formulation of therapeutic strategies targeting aberrant autophagic processes. They stand out in clinical research for their ability to provide insights into therapeutic responsiveness and toxicity in cancer treatment.
The advantages of using CHMP7 Gene Knockout Cell Lines lie in their precision and reliability. Unlike traditional methods of gene knockdown, which can lead to off-target effects and variable expression, these knockout lines provide a consistent model for studying the specific loss-of-function consequences associated with CHMP7. Additionally, researchers benefit from having a robust platform that reduces experimental variability, yielding reproducible results that enhance the reliability of their findings.
For researchers and clinicians aiming to deepen their understanding of cellular mechanisms or advance potential therapeutic avenues, CHMP7 Gene Knockout Cell Lines offer an essential resource. Our company is dedicated to advancing scientific research with high-quality, scientifically accurate biological products, and we are excited to empower scientists with tools that enhance their research capabilities in cellular biology and beyond.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.